Clinical trial
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating
NCT03322072
Study timeline
Study start (actual)2017-11-23Date precision: day
Registry last updated2024-03-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancer Stage Iunresolved
Lung Cancer Stage IIunresolved
Lung Cancer, Nonsmall Cellunresolved
Lung Cancer Recurrentunresolved
Lung Cancer Stage IVunresolved
Interventions
Sponsors & collaborators
CancerCare Manitobalead sponsor
Varian Medical Systemscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03322072 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.